DOHA: According to the EY MENA IPO Eye Q3 2024 report, listings in the MENA region marked a significant year-on-year (YoY) ...

Joseph Pantginis, an analyst from H.C. Wainwright, reiterated the Buy rating on Celldex (CLDX – Research Report). The associated price ...

KSA dominated listing activity with three IPOs The third quarter saw the region’s first non-GCC listing this year in Egypt ...

NDA and MAA for govorestat for treatment of Classic Galactosemia under FDA Priority Review and EMA review; PDUFA target action date of November ...

The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $62.5, a high ...

November 6, 2024MaxCyte, Inc. beats earnings expectations. Reported EPS is $-0.11, expectations were $-0.13. Operator: Hello ...

Tamkeen Human Resources Company, Arabian Company for Agricultural and Industrial Investments, and Nice One Beauty Digital ...

Introduction Postpartum haemorrhage (PPH) remains the leading cause of maternal death. Yet there is a lack of clarity around ...

Even after the cleanup, some of that material settled to the bottom, where it remains. Now fossil fuels again figured in the ...

On Day One, President Trump must take immediate action to protect migrant children by completely overhauling the Office of ...

Palantir’s multi-decade prowess in advanced mission-critical analytics is already making its AI genuinely valuable. Read why ...

DURHAM, N.C., Nov. 08, 2024 (GLOBE NEWSWIRE) -- Humacyte, Inc. (Nasdaq: HUMA), a clinical-stage biotechnology platform company developing universally implantable, bioengineered human tissue at ...